Risultati ricerca pubblicazioni

Thyroid profile during the alternative Sunitinib dosing 2/1 schedule in metastatic renal cell carcinoma

pubblicato su: ENDOCRINE - 2020

Rizza L., Sbardella E., Gianfrilli D., Lauretta R., Tenuta M., Del Bene G., Longo F., Faggiano A., Lenzi A., Giannetta E., Pozza C.

Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: a real-world study

pubblicato su: PANCREATOLOGY - 2018

Rinzivillo Maria, Fazio Nicola, Pusceddu Sara, Spallanzani Andrea, Ibrahim Toni, Campana Davide, Marconicini Riccardo, Partelli Stefano, Badalamenti Giuseppe, Brizzi Maria Pia, Catena Laura, Schinzari Giovanni, Carnaghi Carlo, Berardi Rossana, Faggiano Antongiulio, Antonuzzo Lorenzo, Spada Francesca, Gritti Sara, Femia Daniela, Gelsomino Fabio, Bongiovanni Alberto, Ricci Sergio, Brighi Nicole, Falconi Massimo, Delle Fave Gianfranco, Panzuto Francesco

The innovative potential of statins in cancer: new targets for new therapies

pubblicato su: FRONTIERS IN CHEMISTRY - 2020

Di Bello Elisabetta, Zwergel Clemens, Mai Antonello, Valente Sergio

Editorial: chemical innovative approaches in cancer molecular medicine and translational clinical research

pubblicato su: FRONTIERS IN CHEMISTRY - 2020

Benedetti Rosaria, Conte Mariarosaria, Dell', Aversana Carmela, Hansen Finn K., Zwergel Clemens

PI3K/AKT/mTOR pathway in ovarian cancer treatment: are we on the right track?

pubblicato su: GEBURTSHILFE UND FRAUENHEILKUNDE - 2017

Gasparri Maria Luisa, Bardhi Erlisa, Ruscito Ilary, Papadia Andrea, Farooqi Ammad Ahmad, Marchetti Claudia, Bogani Giorgio, Ceccacci Irene, Mueller Michael D., Benedetti Panici Pierluigi

Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas. effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization

pubblicato su: CELL COMMUNICATION AND SIGNALING - 2020

Fattore L., Malpicci D., Milite C., Castellano S., Sbardella G., Botti G., Ascierto P. A., Mancini R., Ciliberto G.

Cancer stem cells and the slow cycling phenotype. how to cut the gordian knot driving resistance to therapy in melanoma

pubblicato su: CANCERS - 2020

Fattore Luigi, Mancini Rita, Ciliberto Gennaro

Identification and Targeting of Stem Cell-Activated Pathways in Cancer Therapy

pubblicato su: STEM CELLS INTERNATIONAL - 2019

Budillon Alfredo, Curley Steven, Fusco Roberta, Mancini Rita

ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma. Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin

pubblicato su: CANCERS - 2019

Ruggiero Ciro Francesco, Malpicci Debora, Fattore Luigi, Madonna Gabriele, Vanella Vito, Mallardo Domenico, Liguoro Domenico, Salvati Valentina, Capone Mariaelena, Bedogni Barbara, Ascierto Paolo Antonio, Mancini Rita, Ciliberto Gennaro

Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma

pubblicato su: MEDICINE - 2018

Falcone Rosa, Roberto Michela, Filetti Marco, Anselmi Elisabetta, Marchetti Paolo